Related Experiment Videos
Interleukin 6 G-174C polymorphism influences outcome following coronary revascularization surgery
Mohamad N Bittar1, John A Carey, James Barnard
1Department of Cardiothoracic Surgery, South Manchester University Hospitals NHS Trust, Manchester, UK. mbittar@doctors.org.uk
The Heart Surgery Forum
|September 27, 2005
Summary
The interleukin 6 (IL-6) G-174C gene variant influences postoperative IL-6 levels and outcomes after coronary revascularization. The C allele is linked to higher IL-6 and worse clinical results, while the G allele is associated with better outcomes.
Area of Science:
- Cardiovascular Surgery
- Genetics
- Immunology
Background:
- Interleukin 6 (IL-6) is a proinflammatory cytokine that elevates post-surgery.
- The IL-6 G-174C promoter polymorphism is linked to increased coronary heart disease risk.
Purpose of the Study:
- To investigate genetic predisposition in IL-6 response to coronary revascularization.
- To examine the association between the IL-6 G-174C polymorphism, IL-6 levels, and surgical outcomes.
Main Methods:
- Genotyping for the IL-6 G-174C polymorphism in 96 patients undergoing coronary revascularization.
- Measuring postoperative serum IL-6 levels using ELISA.
- Correlating IL-6 levels and genotypes with clinical data.
Main Results:
- The C allele was associated with higher postoperative IL-6 levels (P=.09).
- The G allele was linked to reduced postoperative atrial fibrillation (P=.032) and shorter hospital stays (P=.005).
- Higher IL-6 levels correlated with increased blood loss (P=.016).
Conclusions:
- The IL-6 G-174C polymorphism impacts outcomes following coronary revascularization.
- The C allele is associated with elevated postoperative IL-6 and less favorable clinical results.